Phone
Acknowledgement
2-4 business days
EA Policies for Single Patient
At this point of clinical development, UNION has not established an Expanded Access Program that allows patients access to orismilast outside of clinical trials. Participation in clinical trials will ensure dedicated monitoring of the efficacy and safety of the drug, which is currently the most appropriate and responsible setting of patient treatment.
EA Policies for Disease / Category